USD 0.04
(-10.71%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -1.11 Million USD | 38.95% |
2022 | -1.06 Million USD | 25.98% |
2021 | -2.09 Million USD | 32.56% |
2020 | -1.41 Million USD | -23.7% |
2019 | -3.39 Million USD | 43.5% |
2018 | -4.3 Million USD | 47.28% |
2017 | -7.24 Million USD | -155.04% |
2016 | -2.43 Million USD | 65.83% |
2015 | -9.03 Million USD | -478.51% |
2014 | -14.26 Million USD | -405.74% |
2013 | -245.88 Thousand USD | -567.19% |
2012 | -36.85 Thousand USD | -874.71% |
2011 | 4757.00 USD | 134.05% |
2010 | -13.97 Thousand USD | -21.59% |
2009 | -11.48 Thousand USD | -131.79% |
2008 | 36.22 Thousand USD | 20.46% |
2007 | 48.87 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -172.36 Thousand USD | 26.89% |
2024 Q2 | -197.64 Thousand USD | 2.59% |
2023 Q3 | -43.56 Thousand USD | 83.67% |
2023 Q4 | -179.16 Thousand USD | -311.25% |
2023 Q1 | -74.37 Thousand USD | 80.93% |
2023 Q2 | -266.82 Thousand USD | -258.77% |
2023 FY | - USD | 38.95% |
2022 Q3 | -343.25 Thousand USD | -159.7% |
2022 Q2 | -132.17 Thousand USD | 54.02% |
2022 FY | - USD | 25.98% |
2022 Q4 | -390.02 Thousand USD | -13.62% |
2022 Q1 | -287.47 Thousand USD | 21.8% |
2021 Q3 | -329.71 Thousand USD | 25.69% |
2021 Q4 | -367.62 Thousand USD | -11.5% |
2021 Q1 | -578.2 Thousand USD | 15.43% |
2021 FY | - USD | 32.56% |
2021 Q2 | -443.73 Thousand USD | 23.26% |
2020 Q2 | -405.33 Thousand USD | 34.74% |
2020 FY | - USD | -23.7% |
2020 Q4 | -683.66 Thousand USD | -14.05% |
2020 Q3 | -599.43 Thousand USD | -47.89% |
2020 Q1 | -621.14 Thousand USD | -11.18% |
2019 Q1 | -597.29 Thousand USD | 2.38% |
2019 Q2 | -398.4 Thousand USD | 33.3% |
2019 Q3 | -312.7 Thousand USD | 21.51% |
2019 FY | - USD | 43.5% |
2019 Q4 | -558.67 Thousand USD | -78.65% |
2018 FY | - USD | 47.28% |
2018 Q2 | -952.35 Thousand USD | 30.34% |
2018 Q3 | -584.33 Thousand USD | 38.64% |
2018 Q4 | -611.83 Thousand USD | -4.71% |
2018 Q1 | -1.36 Million USD | 11.87% |
2017 Q3 | -999.54 Thousand USD | 44.56% |
2017 Q2 | -1.8 Million USD | 5.85% |
2017 FY | - USD | -155.04% |
2017 Q1 | -1.91 Million USD | -18.0% |
2017 Q4 | -1.55 Million USD | -55.2% |
2016 Q3 | -425.6 Thousand USD | -649.53% |
2016 Q2 | -56.78 Thousand USD | 81.35% |
2016 Q4 | -1.62 Million USD | -281.29% |
2016 FY | - USD | 65.83% |
2016 Q1 | -304.43 Thousand USD | 83.67% |
2015 Q2 | -1.83 Million USD | -5.16% |
2015 FY | - USD | -478.51% |
2015 Q4 | -1.86 Million USD | -6.14% |
2015 Q3 | -1.75 Million USD | 4.09% |
2015 Q1 | -1.74 Million USD | -83.63% |
2014 FY | - USD | -405.74% |
2014 Q3 | -131.24 Thousand USD | -31.46% |
2014 Q2 | -99.83 Thousand USD | -56.02% |
2014 Q4 | -948.45 Thousand USD | -622.67% |
2014 Q1 | -63.98 Thousand USD | 99.8% |
2013 Q1 | -3380.00 USD | 81.72% |
2013 FY | - USD | -567.19% |
2013 Q3 | -87.55 Thousand USD | -17234.25% |
2013 Q4 | -32.37 Million USD | -36871.43% |
2013 Q2 | 511.00 USD | 115.12% |
2012 Q4 | -18.48 Thousand USD | 22.86% |
2012 Q1 | 2709.00 USD | 121.97% |
2012 Q2 | 2889.00 USD | 6.64% |
2012 Q3 | -23.96 Thousand USD | -929.49% |
2012 FY | - USD | -874.71% |
2011 FY | - USD | 134.05% |
2011 Q4 | -12.33 Thousand USD | -754.61% |
2011 Q2 | 7209.00 USD | -36.33% |
2011 Q3 | -1443.00 USD | -120.02% |
2011 Q1 | 11.32 Thousand USD | 223.36% |
2010 Q2 | -5746.00 USD | -152.91% |
2010 Q1 | 10.85 Thousand USD | 215.46% |
2010 Q3 | -9904.00 USD | -72.36% |
2010 FY | - USD | -21.59% |
2010 Q4 | -9179.00 USD | 7.32% |
2009 FY | - USD | -131.79% |
2009 Q4 | -9405.00 USD | -32.61% |
2009 Q1 | 10.27 Thousand USD | 202.7% |
2009 Q2 | -5261.00 USD | -151.23% |
2009 Q3 | -7092.00 USD | -34.8% |
2008 FY | - USD | 20.46% |
2008 Q4 | -10 Thousand USD | -549755813887999900.0% |
2008 Q1 | 20 Thousand USD | 0.0% |
2008 Q3 | - USD | -100.0% |
2008 Q2 | 20 Thousand USD | 0.0% |
2007 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Achiko AG | -8.32 Million USD | 86.613% |
Accelera Innovations, Inc | - USD | Infinity% |
Aspyra Inc. | -2.84 Million USD | 60.843% |
CompuMed, Inc. | 690.19 Thousand USD | 261.482% |
CompuGroup Medical SE & Co. KGaA | 212.78 Million USD | 100.524% |
Cogstate Limited | 9.89 Million USD | 111.268% |
CareView Communications, Inc. | -210.04 Thousand USD | -430.626% |
Craneware plc | 54.26 Million USD | 102.054% |
Caduceus Software Systems Corp. | -12.29 Million USD | 90.933% |
Certive Solutions Inc. | -704.66 Thousand USD | -58.165% |
Drug Free Solution, Inc. | -1.39 Million USD | 20.101% |
DATATRAK International, Inc. | 2.72 Million USD | 140.847% |
Strainsforpains, Inc. | -65.61 Thousand USD | -1598.724% |
Healixa Inc. | -6.32 Million USD | 82.366% |
Easy Technologies Inc. | - USD | Infinity% |
eWellness Healthcare Corporation | - USD | Infinity% |
Founders Bay Holdings | 10.16 Million USD | 110.961% |
Health Discovery Corporation | - USD | Infinity% |
Healthcare Integrated Technologies, Inc. | -425.48 Thousand USD | -161.942% |
H-Source Holdings Ltd. | - USD | Infinity% |
InterCare DX, Inc. | - USD | Infinity% |
IQ-AI Limited | -370.35 Thousand USD | -200.938% |
Cannabiz Mobile, Inc. | -750.00 USD | -148504.4% |
Mednow Inc. | -28.12 Million USD | 96.037% |
Galileo Life Sciences, Inc. | -270.72 Thousand USD | -311.688% |
MediXall Group, Inc. | -6.52 Million USD | 82.915% |
Mitesco, Inc. | -11.96 Million USD | 90.684% |
MobileSmith, Inc. | -13.83 Million USD | 91.946% |
NantHealth, Inc. | -38.53 Million USD | 97.108% |
Net Medical Xpress Solutions, Inc. | -1.69 Million USD | 34.362% |
OneLife Technologies Corp. | - USD | Infinity% |
ORHub, Inc. | -12.08 Million USD | 90.779% |
Patient Access Solutions, Inc. | -12.09 Million USD | 90.788% |
Pharma-Bio Serv, Inc. | 1.31 Million USD | 184.967% |
PPJ Healthcare Enterprises, Inc. | 74.73 Thousand USD | 1591.413% |
Medical Cannabis Payment Solutions, Inc. | -12.18 Thousand USD | -9047.513% |
Renalytix Plc | -28.52 Million USD | 96.092% |
Revium Recovery Inc. | -678 Thousand USD | -64.385% |
RYAH Group, Inc. | - USD | Infinity% |
Carepay Inc. | -369.00 USD | -301941.463% |
Vaso Corporation | 4.19 Million USD | 126.568% |
Vynleads, Inc. | -235.72 Thousand USD | -372.809% |